title: Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study.
abstract: Crohn's disease (CD) is associated with a higher type-1-helper T cell (Th1) cytokine expression, whereas ulcerative colitis (UC) appears to express a modified Th2 response. In addition to its classic role in calcium homeostasis, calcitriol, the hormonal active form of vitamin D, exerts immunoregulatory effects such as modulation of Th1/Th2 cytokines. Therefore, calcitriol administration could modify immune dysfunction in CD and UC. Nine patients with UC (M/F: 5/4; mean age 47 years, remission(R)/active(A) disease: 7/2), 8 patients with CD (M/F: 2/6; mean age 36, R/A 5/3) and 6 healthy controls (HC) (M/F: 3/3, mean age 4) were enrolled. Peripheral blood was collected after a drug-washout of 15 days and peripheral blood mononuclear cells were stimulated with mitogens alone or in the presence of physiological concentrations of calcitriol (100 pg/ml). Type 1 (IL-2, TNF-alpha, IFN-gamma) and type 2 (IL-10) cytokine production was assayed on supernatants by ELISA. Compared to HC, TNF-alpha production was significantly higher both in UC (p=0.0002) and CD (p=0.0001) patients, at baseline and after incubation with calcitriol (UC p=0.0003, CD p=0.0009). The effects of calcitriol incubation were: 1) reduced IFN-gamma (p=0.024) and increased IL-10 (p=0.06) production in UC patients; 2) reduced TNF-alpha production in CD (p=0.032); 3) no significant effects in HC. Calcitriol increased, albeit not significantly, IL-10 production in UC compared to CD patients (p=0.09). These results suggest an important modulatory role of vitamin D in the Th1/Th2 immune response. The observation that the effect of this modulation was different in CD compared to UC patients provides an interesting area of research into the pathogenesis and treatment of these inflammatory conditions.
authors.affiliation: Gastroenterology Unit, Department of Clinical Science, L. Sacco University Hospital, Milano, Italy. samari1@tin.it
authors.forename: S
authors.initials: S
authors.lastname: Ardizzone
authors.forename: A
authors.initials: A
authors.lastname: Cassinotti
authors.forename: D
authors.initials: D
authors.lastname: Trabattoni
authors.forename: G
authors.initials: G
authors.lastname: Manzionna
authors.forename: V
authors.initials: V
authors.lastname: Rainone
authors.forename: M
authors.initials: M
authors.lastname: Bevilacqua
authors.forename: A
authors.initials: A
authors.lastname: Massari
authors.forename: G
authors.initials: G
authors.lastname: Manes
authors.forename: G
authors.initials: G
authors.lastname: Maconi
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: G
authors.initials: G
authors.lastname: Bianchi Porro
mesh_terms: D000328:Adult; D000368:Aged; D002117:Calcitriol / Q000494:pharmacology*; D016207:Cytokines / Q000097:blood*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D015212:Inflammatory Bowel Diseases / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*
chemical_list: D016207:Cytokines; D007155:Immunologic Factors; D002117:Calcitriol